MariMed Inc. (MRMD.CN)
CAD 0.15
(-11.76%)
CAD 0.15
(-11.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 148.59 Million USD | 10.89% |
| 2022 | 134.01 Million USD | 10.33% |
| 2021 | 121.46 Million USD | 138.66% |
| 2020 | 50.89 Million USD | 11.6% |
| 2019 | 45.6 Million USD | 284.79% |
| 2018 | 11.85 Million USD | 95.32% |
| 2017 | 6.06 Million USD | 70.25% |
| 2016 | 3.56 Million USD | 180.6% |
| 2015 | 1.27 Million USD | 1337.11% |
| 2014 | 88.38 Thousand USD | 9676.99% |
| 2013 | 904.00 USD | 15.16% |
| 2012 | 785.00 USD | -99.38% |
| 2011 | 125.6 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 40.43 Million USD | 6.6% |
| 2024 Q1 | 37.93 Million USD | -2.48% |
| 2023 Q2 | 36.51 Million USD | 6.22% |
| 2023 Q4 | 38.89 Million USD | 0.26% |
| 2023 Q1 | 34.38 Million USD | -4.05% |
| 2023 Q3 | 38.8 Million USD | 6.25% |
| 2023 FY | 148.59 Million USD | 10.89% |
| 2022 Q1 | 31.28 Million USD | 0.77% |
| 2022 Q3 | 33.91 Million USD | 2.81% |
| 2022 Q4 | 35.83 Million USD | 5.66% |
| 2022 FY | 134.01 Million USD | 10.33% |
| 2022 Q2 | 32.98 Million USD | 5.45% |
| 2021 Q2 | 32.56 Million USD | 32.17% |
| 2021 Q4 | 31.04 Million USD | -6.52% |
| 2021 Q1 | 24.64 Million USD | 21.05% |
| 2021 FY | 121.46 Million USD | 138.66% |
| 2021 Q3 | 33.2 Million USD | 1.96% |
| 2020 FY | 50.89 Million USD | 11.6% |
| 2020 Q1 | 7.46 Million USD | 43.79% |
| 2020 Q2 | 9.61 Million USD | 28.72% |
| 2020 Q3 | 13.46 Million USD | 40.07% |
| 2020 Q4 | 20.35 Million USD | 51.23% |
| 2019 Q1 | 3.51 Million USD | 2.2% |
| 2019 Q4 | 5.19 Million USD | -53.74% |
| 2019 Q3 | 11.22 Million USD | -56.28% |
| 2019 FY | 45.6 Million USD | 284.79% |
| 2019 Q2 | 25.67 Million USD | 630.21% |
| 2018 Q2 | 2.93 Million USD | 41.02% |
| 2018 Q4 | 3.44 Million USD | 1.43% |
| 2018 Q1 | 2.08 Million USD | 31.8% |
| 2018 FY | 11.85 Million USD | 95.32% |
| 2018 Q3 | 3.39 Million USD | 15.46% |
| 2017 FY | 6.06 Million USD | 70.25% |
| 2017 Q4 | 1.58 Million USD | -7.89% |
| 2017 Q1 | 1.15 Million USD | -19.46% |
| 2017 Q2 | 1.62 Million USD | 40.87% |
| 2017 Q3 | 1.71 Million USD | 5.84% |
| 2016 Q1 | 614.45 Thousand USD | -15.43% |
| 2016 FY | 3.56 Million USD | 180.6% |
| 2016 Q4 | 1.42 Million USD | 63.55% |
| 2016 Q3 | 873.54 Thousand USD | 34.92% |
| 2016 Q2 | 647.44 Thousand USD | 5.37% |
| 2015 Q1 | 96.23 Thousand USD | 9.72% |
| 2015 Q3 | 392.83 Thousand USD | 620.64% |
| 2015 FY | 1.27 Million USD | 1337.11% |
| 2015 Q4 | 726.59 Thousand USD | 84.96% |
| 2015 Q2 | 54.51 Thousand USD | -43.36% |
| 2014 Q4 | 87.7 Thousand USD | 37542.49% |
| 2014 FY | 88.38 Thousand USD | 9676.99% |
| 2014 Q3 | 233.00 USD | 4.95% |
| 2014 Q2 | 222.00 USD | 0.0% |
| 2014 Q1 | 222.00 USD | 4.23% |
| 2013 Q3 | 352.00 USD | 175.0% |
| 2013 Q4 | 213.00 USD | -39.49% |
| 2013 FY | 904.00 USD | 15.16% |
| 2013 Q1 | 210.00 USD | 56.72% |
| 2013 Q2 | 128.00 USD | -39.05% |
| 2012 Q3 | 219.00 USD | -9.5% |
| 2012 Q4 | 134.00 USD | -38.81% |
| 2012 Q2 | 242.00 USD | 27.37% |
| 2012 Q1 | 190.00 USD | 0.0% |
| 2012 FY | 785.00 USD | -99.38% |
| 2011 Q2 | 50.31 Thousand USD | 0.0% |
| 2011 FY | 125.6 Thousand USD | 0.0% |
| 2011 Q3 | 25.23 Thousand USD | -49.84% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aion Therapeutic Inc. | 367.47 Thousand CAD | -40337.141% |
| Ayurcann Holdings Corp. | 25.15 Million CAD | -490.668% |
| Blueberries Medical Corp. | 288.27 Thousand CAD | -51447.844% |
| The BC Bud Corporation | 61.48 Thousand CAD | -241593.504% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -39819.193% |
| CordovaCann Corp. | 13.59 Million CAD | -993.058% |
| Christina Lake Cannabis Corp. | 11.77 Million CAD | -1161.477% |
| Captor Capital Corp. | 36.76 Million CAD | -304.172% |
| City View Green Holdings Inc. | 8582.00 CAD | -1731407.807% |
| 1CM Inc. | 35.34 Million CAD | -320.464% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -2741.157% |
| IM Cannabis Corp. | 48.8 Million CAD | -204.479% |
| Lobe Sciences Ltd. | 840.53 Thousand CAD | -17578.999% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -247563.333% |
| Nextleaf Solutions Ltd. | 8.17 Million CAD | -1716.687% |
| Ovation Science Inc. | 61.93 Thousand CAD | -239829.602% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -84916.62% |
| RAMM Pharma Corp. | 5.06 Million CAD | -2833.669% |
| RIV Capital Inc. | 7.48 Million CAD | -1884.465% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 88.33 Million CAD | -68.224% |
| SLANG Worldwide Inc. | 35.68 Million CAD | -316.448% |
| 1933 Industries Inc. | 18.27 Million CAD | -713.198% |
| Red Light Holland Corp. | 4.75 Million CAD | -3027.075% |
| Top Strike Resources Corp. | 13.32 Million CAD | -1014.987% |
| Xebra Brands Ltd. | 106.85 Thousand CAD | -138965.088% |
| Adastra Holdings Ltd. | 22.22 Million CAD | -568.678% |